CompuGroup Medical SE & Co. KGaA (XTRA:COP) agreed to acquire Medicus LIS on November 22, 2022. Co-founder and President Karen Bornstein is committed to stay on board, and the transaction is expected to still close in November 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.31 EUR | +1.62% | -3.70% | -25.75% |
Apr. 25 | COMPUGROUP MEDICAL : Jefferies gives a Neutral rating | ZD |
Apr. 18 | COMPUGROUP MEDICAL : Gets a Buy rating from Deutsche Bank | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.75% | 1.56B | |
+8.97% | 316B | |
+24.82% | 212B | |
+11.25% | 56.54B | |
+9.57% | 32.23B | |
+2.55% | 29.66B | |
+96.39% | 21.88B | |
+20.22% | 19.71B | |
-0.43% | 14.5B | |
+11.30% | 14.46B |
- Stock Market
- Equities
- COP Stock
- News CompuGroup Medical SE & Co. KGaA
- CompuGroup Medical SE & Co. KGaA agreed to acquire Medicus LIS.